RECOMBITEK Equine West Nile Virus Vaccine
Merial RECOMBITEK Equine West Nile
Virus Vaccine is recommended
for the vaccination of healthy horses as an aid in the prevention of viremia
due to West Nile Virus infection.
RECOMBITEK WNV contains a lyophilized recombinant canarypox vectored West Nile Virus
vaccine plus a sterile liquid diluent. A canarypox vector has been modified
using recombinant technology to express the desired antigens capable of
stimulating a protective immune response to West Nile Virus. After
inoculation, the vector does not multiply in the horse, but does express the
protective proteins. As a consequence, these components induce an immune
status against West Nile Virus. Safety and immunogenicity of this vaccine
have been demonstrated by vaccination and challenge tests in susceptible
DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid
diluent and aseptically inject a 1 ml dose by intramuscular route. For
primary vaccination, revaccinate with a second 1 ml dose of this product 4
to 6 weeks later. Annual revaccination with a single dose is recommended.
PRECAUTIONS: Store at 2-7°C (35-45°F). For the preparation and
administration of the vaccine, use sterile and antiseptic-free and/or
disinfectant-free material. Burn container and all unused contents. Contains
gentamicin as a preservative. Do not vaccinate within 21 days prior to
slaughter. As with any vaccine, a hypersensitivity reaction may occur, which
may require appropriate symptomatic treatment.
For Veterinary Use Only.
10 x 1 dose (1 mL)
10 x 1 Dose, Lyophilized
10 x 1 mL, Sterile Water
5 x 5 dose (5 mL)
5 x 5 Dose, Lyophilized
5 x 5 mL, Sterile Diluent